Life Sciences Commercialisation in Finland: Overview - Dittmar & Indrenius

Service areas

Written by

Charlotta Bonsdorff

Senior Associate

Juli Mansnérus

Partner

[email protected] +358 44 272 4727

Inari Kinnunen

Senior Attorney

[email protected] +358 50 388 9591

Emilia Rosenblad

Associate

[email protected]

A Q&A guide to life sciences commercialisation in Finland.

This Q&A provides a high-level overview of key practical issues, including the life sciences sector, pricing and state funding, distribution and sale, importing, advertising, patents, trade marks, competition law, and product liability.

Read the Finland chapter we contributed: Life Sciences Commercialisation in Finland: Overview

Read also: Life Sciences Regulation in Finland: Overview

Written by

Charlotta Bonsdorff

Senior Associate

Juli Mansnérus

Partner

[email protected] +358 44 272 4727

Inari Kinnunen

Senior Attorney

[email protected] +358 50 388 9591

Emilia Rosenblad

Associate

[email protected]

Service areas

More by the same author

New Legislation on Environmental Marketing: Sustainable Businesses Benefit from Ban on Greenwashing

New EU legislation on green claims will bring opportunities to sustainable businesses, although ensuring compliance with the new rules will require preparatory efforts from companies. As stricter and more detailed rules will apply to environmental claims and marketing, to prevent so-called greenwashing, companies with a genuinely sustainable product range will benefit from the new framework. Prohibition of greenwashing brings advantages to both consumers and businesses – and naturally to the environment.

The EU’s Pharmaceutical Legislation Reform

The European Union’s imminent pharmaceutical legislation reform aims to modernise its regulatory framework, focusing on improving patient access to medicines, fostering innovation, and minimising environmental impact. This strategic overhaul, set against a backdrop of industry challenges and evolving IP rights, underscores the EU’s commitment to balancing innovation with accessibility and sustainability in healthcare.

The European Parliament and the Council reach an agreement on European Health Data Space!

Towards a stronger European Health Union On March 15, 2024, the European Parliament and the Belgian Presidency of the Council reached a provisional political agreement on the European Health Data Space (EHDS) which is considered one of the central building blocks towards a stronger European Health Union. The upcoming EHDS aims to harness the full potential offered by the sharing, use, and re-use of health data, while ensuring full compliance with the data protection standards in the EU. This marks a significant milestone in the EU’s health data regulation.

Latest insights

Are Finnish Lawyers the Happiest in the World?

Article / 4 Apr 2024

Reading time 2 minutes

Implementing the Data Act without Clashing with the GDPR?

Article / 4 Apr 2024